Browse > Article
http://dx.doi.org/10.15204/jkobgy.2010.23.2.001

Effects of Gaeullijin-Tang on the Progression of the Estradiol Valerate-induced Polycystic Ovaries in Rats  

Yun, Mun-Hui (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University)
Lee, Dong-Nyung (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University)
Seo, Il-Bock (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University)
Kim, Hyung-Jun (Dept. of Oriental Gynecology, College of Oriental Medicine, Se-Myung University)
Publication Information
The Journal of Korean Obstetrics and Gynecology / v.23, no.2, 2010 , pp. 1-19 More about this Journal
Abstract
Purpose: This study was designed to investigate the effects of Gaeullijin-Tang(GIT) on the progression of the estradiol valerate(EV)-induced polycystic ovaries(PCO) in rats. Methods: PCO was induced by single intramuscular injection with estradiol valerate(EV)(4mg) in female rats. Normal group(n=8) were injected with sesame oil and orally administrated distilled water for sixty days. PCO control group (n=8) were injected with EV and orally administrated distilled water for sixty days. GIT treated group(n=8) were injected with EV and orally administrated GIT for same duration. At the end day of experiment, we measured weights of body, ovaries, adrenal glands, uterus and contents of serum androsternedione (ADD) and total estrogen. The histomorphometrical changes of ovaries were also evaluated. And we observed the NGF and CRF expression by immunohistochemistry. Results: The results were as follows - The weights(mg) of ovaries in GIT treated group($75.5{\pm}4.3$) were significantly increased(p<0.001) compared with PCO control group($54.3{\pm}4.5$). - The numbers of mature follicles in GIT treated group($5.3{\pm}1.2$) were significantly increased(p<0.05) compared with PCO control group($3.5{\pm}1.2$). - The numbers of corpora lutea in GIT treated group($1.8{\pm}1.3$) were significantly increased(p<0.05) compared with PCO control group($0.3{\pm}0.7$). Conclusion: From the above results, we concluded that Gaeullijin-Tang(GIT) contributes to stimulating normally ovulation by decreasesing ovarian NGF concentrations.
Keywords
Gaeullijin-Tang; Polycystic Ovaries(PCO); Estradiol Valerate(EV); Nerve Growth Factor(NGF); Ovarian Histopathology;
Citations & Related Records
Times Cited By KSCI : 8  (Citation Analysis)
연도 인용수 순위
1 Taylor AE et al. Determinants of abnormal gonadotropin secretion in clinical defined women woth polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism. 1997;82 :2248-56.   DOI   ScienceOn
2 Azziz R et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome:an Androgen Excess Society guideline. Journal of Clinical Endocrinology & Metabolism. 2006;91:4237-45.   DOI   ScienceOn
3 Hahn S et al. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine- Westphalia. Hormone and Metabolic Research. 2005;37:438-44.   DOI   ScienceOn
4 Lala HE et al. An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology. 2000 ;141:1059-72.   DOI   ScienceOn
5 Schulster A, Farookhi R, Brawer JR. Polycystic ovarian condition in estradiol valerate -treated rat: Spontaneous changes in characteristic endocrine features. Biology of Reproduction. 1984;31:587-93.   DOI   ScienceOn
6 Conway GS, Honour JW, Jacobs HS. Heterogeneity of the polycystic ovary syndrome: clinical, endocrine and ultrasound features in 556 patients. Clinical Endocrinology. 1989;30:459-70.   DOI
7 남은정 등. 定經湯이 estradiol valerate로 유발된 흰쥐의 다낭성 난소에 미치는 영향. 대한한방부인과학회지. 2007;20(1):99-113.   과학기술학회마을
8 Manni L et al. Effects of exrecise on ovarian morphology and expression of nerve growth factor and $\alpha_1$-and $\beta_2$-adrenergic receptors in rats with steroid-induced polycystic ovaries. Journal of Neuroendocrinology. 2005; 17:846-58.
9 양승정 등. 蒼附導痰湯이 estradiol valerate로 유발된 백서의 다낭성 난소에 미치 는 影響. 대한한방부인과학회지. 2002;15(2):1-11.   과학기술학회마을
10 Arroyo A et al. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity. Journal of Clinical Endocrinology & Metabolism. 1997;82:3728-33.   DOI   ScienceOn
11 Anttila L et al. Clinical features and circulating gonadotropin, insulin, and androgen interactions in women with polycystic ovarian disease. Fertil and Steril. 1991;55:1057-61.   DOI
12 Lergo RS, Kunselman AR, Dunaif A. Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome. The American journal of medicine. 2001;111:607-13.   DOI   ScienceOn
13 Santbrink EJ, Hop WC, Fauser BC. Classification of normogonadotropic infertility:polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil and Steril. 1997;67:452-8.   DOI   ScienceOn
14 Lergo RS et al. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Journal of Clinical Endocrinology & Metabolism. 1999;84:165-9.   DOI   ScienceOn
15 Rebar R et al. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism. 1976;57:1320-9.
16 Aguado LI, Petrovic SL, Ojeda SR. Ovarian $\beta$-adrenergic receptors during the onset of puberty: characterization, distribution, and coupling to steroidogenic responses. Endocrinology. 1982;110(4):1124-32.   DOI   ScienceOn
17 Dyer CA, Erickson GF. Norepinephrine amplifies human chorionic gonadotropin -stimulated androgen biosynthesis by ovarian theca-interstitial cells. Endocrinology. 1985;116(4):1645-52.   DOI   ScienceOn
18 Dissen GA et al. Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology. 2000;141(3):1073-81.   DOI   ScienceOn
19 DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil and Steril. 2005;83:1454-1460.   DOI   ScienceOn
20 Lergo RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism. 1998;93:2694-8.
21 허 준. 동의보감. 서울:법인문화사. 2002;290, 291, 362.
22 Levin N et al. Decreased food intake does not completely account for adiposity reduction after ob protein infusion. Proceedings of the National Academy of Sciences of the United States of America. 1996;93(4):1726-30.   DOI   ScienceOn
23 Stener VE. Acupuncture in reproductive medicine: Overview and summary of recent studies. International Congress Series. 2002;1238:149-56.   DOI   ScienceOn
24 Carmina E et al. Difference in body weight between American and Italian women with polycystic ovary syndrome :influence of the diet. Human Reproduction. 2003;18:2289-93.   DOI   ScienceOn
25 Levi MR. The nerve growth factor 35 years later. Science. 1987;237:1154-62.   DOI
26 The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and ling term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-7.   DOI   ScienceOn
27 Azziz R et al. Androgen excess in women: experience with over 1000 consecutive patients. Journal of Clinical Endocrinology & Metabolism. 2004;89:453-62.   DOI   ScienceOn
28 Anderson E, Lee GY, O'Brien K. Polycystic ovarian condition in the dehydroepiandrosterone-treated rat model: Hyperandrogenism and the resumption of meiosis are major initial events associated with cystogenesis of antral follicles. Reproductive Biology. 1998;249(1):44-53.
29 Halaas JL et al. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223) :543-6.   DOI
30 전국한의과대학본초학교실. 본초학. 서울:영림사. 2000:290, 303, 348, 349, 353, 355, 379, 409, 417, 448, 541.
31 Barb CR et al. Inhibition of ovulation and LH secretion in the gilt after treatment with ACTH or hydrocortisone. Journal of Reproduction and Fertility. 1982;64(1):85-92.   DOI   ScienceOn
32 Conway GS et al. Effects of Luteinizing Hormone, Insulin, Insulin-like Growth Factor-I and Insulin-like Growth Factor Small Binding Protein 1 in the Polycystic Ovary Syndrome. Clinical Endocrinology. 1990;33:596-603.
33 Stener VE et al. Effects of electro -acupuncture on corticotropin-releasing factor in rats with experimentallyinduced polycystic ovaries. Neuropeptides. 2001;35(5&6):227-31.   DOI   ScienceOn
34 김근우, 구병수. 항(抗) Stress 실험에관한 비교 연구. 동의신경정신과학회지. 1997;8(1):111-25.
35 한의부인과학 편찬위원회. 한의부인과학(上). 서울:정담. 2002:126, 410.
36 Stener VE et al. Effects of eletro -acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biology of Reproduction. 2000;63(5):1497-503.   DOI   ScienceOn
37 김희주, 김윤상, 임은미. 蒼附六君湯이 estradiol valerate로 유발된 흰쥐의 다낭성 난소에 미치는 영향. 대한한방부인과학회지. 2008;21(2):1-16.   과학기술학회마을
38 윤소영, 강명자. 다낭성 난소증후군환자의 한방 치료에 대한 임상적 고 찰. 대한한방부인과학회지. 2000;13(2):437-51.
39 이연경 등. 歸脾湯이 estradiol valerate로 유발된 흰쥐의 다낭성 난소에 미치는 영향. 대한한방부인과학회지. 2008;21(3):60-74.   과학기술학회마을
40 유영기 등. 腎氣丸合蒼附導痰湯이 estradiolvalerate로 유발된 흰쥐의 다낭성 난소에 미치는 영향. 대한한방부인과학회지. 2007;20(1):84-98.   과학기술학회마을
41 김세련, 김종욱. 고인슐린 혈증과 다낭성난소증후군의 병태 생리. 관동의대학술지. 2005;9(1):89-98.
42 Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome :towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. 3rd ed. Boston. Blackwell Scientific Publication. 1992;377-84.
43 The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and ling term health risks related to polycystic ovary syndrome. Fertil and Steril. 2004;81:19-25.
44 김 탁. 다낭성 난소 증후군의 최신 지견. 대한산부인과학회 연수강좌. 2002;31 :38-44.
45 Stener VE et al. Rats with steroid -induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reproductive Biology and Endocrinology. 2005;3:44.   DOI   ScienceOn
46 Polson DW et al. Polycystic ovaries-a common finding in normal women. The Lancet. 1988;1:870-2.
47 Balen AH et al. Ultrasound assessment of the polycystic ovary:international consensus definitions. Human Reproduction Update. 2003;9:505-14.   DOI   ScienceOn
48 민응기. 다낭성 난소 증후군. 대한산부인과학회지. 2008;51(8):805-19.
49 吳桂芳, 李祥云. 中醫學治療多囊卵巢 綜合症硏究槪況. 河南中醫. 1994;14(2) :123-5.
50 Baillargeon JP. Use of insulin sensitizers in polycystic ovarian syndrome. Current Opinion in Investigational Drugs. 2005;6:1012-22.
51 金維新. 不孕症的診斷與中醫治療. 北京:科學出版社. 1992:172-7.
52 萬全. 萬氏婦人科. 湖北省:湖北人民出版社. 1983:9-10.
53 이혜진, 성연아. 다낭난소증후군의 진단과 치료. 대한내분비학회지. 2007;22(4):252-6.
54 Brawer JR, Munoz M, Farookhi R. Development of the polycystic ovarian condition(PCO) in the estradiol valerate -treated rat. Biology of Reproduction. 1986;35:647-55.   DOI   ScienceOn
55 Brawer JR et al. Effects of a single injection of estradiol valerate on the hypothalamic arcuate nucleus and on reproductive function in the female rat. Endocrinology. 1978;103:501-12.   DOI   ScienceOn
56 대한산부인과학회 교과서편찬위원회.부인과학. 서울:고려의학. 2007:63, 362.
57 김동일, 윤종원, 이태균. 다낭성 난소증후군에 관한 문헌적 고찰. 대한한방부인과학회지. 1997;10(1):73-91.
58 김정훈. 다낭성난소증후군 치료의 최신지견. 대한산부인과학회지. 2005;48(8) :1851-69.
59 Krysiak R et al. Update on the management of polycystic ovary syndrome. Pharmacological Reports. 2006;58(5):614-25.